Studies related to Blood glucose and Chromium

Role Of Chromium Supplementation In Indians With Type 2 Diabetes Mellitus

Effect Decrease
Trial Design Double blind
Trial Length 6+ Months
Number of Subjects 93
Sex Both Genders
Age Range 45-64
Body Types Average
Notes for this study:
Supplementation of chromium to type II diabetics for 28 weeks noted a reduction in blood glucose relative to baseline and placebo, and the minor changes in HbA1c and insulin turned out to be significant due to an increase seen in placebo. Weight and blood pressure were not significantly different, nor were any parameter of lipid metabolism measured.

Full details on all 29 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.